大象传媒

Home
Research Group in Molecular Pathology

Selected publications

Selected publications (since 2005)

Photo:
www.colourbox.no

Main content

  1. Haugland HK, Jebsen NL, Mannelqvist M, Skar R, Eide J, 脴vreb酶 K, Horn A, Jensen DK, Monge OR, Lilleng PK. Treatment of patients with gastrointestinal stromal tumour with imatinib mesylate. [Norwegian]. Tidsskrift for Den norske legeforening 2005; 125: 868-72.

  2. Costea DE, Kulasekara KK, E. Neppelberg,聽 Johannessen AC, Vintermyr OK.Species-specific聽 fibroblasts required for triggering invasiveness of partially transformed oral keratinocytes. Am. J. Pathol. 2006; 168: 1889-97.

  3. Steigen SE, Bjerkehagen B, Haugland HK, Nordrum IS, L酶berg EM, Isaksen V, Eide TJ, Nielsen TO. Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway. Mod. Pathol. 2008; 21: 46-53.

  4. Lukandu O, Costea DE, Neppelberg E, Johannessen AC, Vintermyr OK. Khat (Catha edulis) induces reactive oxygen species and apoptosis in normal human oral keratinocytes and fibroblasts. Toxicological Sci. 2008; 103: 311-324.

  5. Vintermyr OK, Skar R, Iversen OE, Haugland HK. Usefulness of HPV test on cell sample from the cervix. [Norwegian]. Tidsskrift for Den norske legeforening 2008; 128: 171-173.

  6. Kalungi S, Steine SJ, Wabinga H, Bostad L, Molven A. pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from Uganda. BMC Clin. Path. 2009; 9: 6 (1-7).

  7. Kalungi S, Wabinga H, Molven A, Bostad L. Lymphomas diagnosed in Uganda during the HIV/AIDS pandemic. East Afr. Med. J. 2009; 86: 226-32.

  8. Mangseth K, Helgeland L, Klos J, Molven A, Vintermyr OK. Improved diagnostic segregation of mantle cell lymphoma by determination of cyclin D1/D3 expression ratio in formalin-fixed tissue. Diagn. Mol. Pathol. 2009; 18: 150-5.

  9. Berget E, Helgeland L, Molven A, Vintermyr OK. Detection of clonality in follicular lymphoma using formalin fixed, paraffin embedded tissue samples and BIOMED-2 immunoglobulin primers. J. Clin. Path. 2011; 64: 37-41.

  10. Haugland HK, Casati B, D酶rum LM, Bjugn R. Template reporting matters--a nationwide study on histopathology reporting on colorectal carcinoma resections. Hum. Pathol. 2011; 42: 36-40.

  11. Revheim ME, Hole KH, Bruland OS, Haugland HK, Hall KS, Seierstad T. DW MRI for evaluation of treatment response to imatinib in a rectal gastrointestinal stromal tumour. Acta Oncol. 2011; 50: 148-50.

  12. Tr酶nnes H, Haugland HK, B茅k谩ssy AN, Helle SI, Sorbye H. Small cell lung cancer in a 14-year-old girl. J. Pediatr. Hematol. Oncol. 2012; 34: e86-8.

  13. S酶reide K, Sandvik OM, S酶reide JA, Gudlaugsson E, Mangseth K, Haugland HK. Clin. Transl. Oncol. 2012; 14: 619-29.

  14. Brustugun OT, Helland 脜, Fjellbirkeland L, Kleinberg L, Ariansen S, Jebsen P, Scott H, D酶nnem T, Bremnes R, Berg T, Gr酶nberg BH, Dai HY, Wahl SG, Mangseth K, Helgeland L. Mutation testing for non-small-cell lung cancer. [Norwegian]. Tidsskrift for Den norske legeforening 2012; 132: 952-5.

  15. Berget E, Helgeland L, Lehmann AK, Smievoll AI, Vintermyr OK, M酶rk SJ. Primary diffuse large B-cell lymphoma of the dura without systemic recurrence after diagnosis and successful therapy. Acta Oncol. 2013; 52: 1047-9.

  16. , , , , , , , , , , , , , , , , , , , , , . EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. 2013; 125: 683-98.

  17. Bredholt T, Ersv忙r E, Erikstein BS, Sulen A, Reikvam H, Aarstad HJ, Johannessen AC, Vintermyr OK, Bruserud 脴, Gjertsen BT. Distinct single cell signal transduction signatures in leukocyte subsets stimulated with khat extract, amphetamine-like cathinone, cathine or norephedrine. BMC Pharmacol. Toxicol. 2013, 11;14:35.

  18. Talasila KM, Brekka N, Mangseth K, Stieber D, Evensen L, Rosland GV, Torsvik A, Wagner M, Niclou SP, Mahesparan R, Vintermyr OK, Bjerkvig R, Nigro JM, Miletic H. Tumor versus Stromal Cells in Culture-Survival of the Fittest? PLoS One. 2013 Dec 2;8(12):e81183.

  19. Budal EB, Haugland HK, Skar R, Maehle BO, Bj酶rge T, Vintermyr OK. HPV DNA testing improves CIN2+ risk stratification and detection of CIN2+ in delayed triage of ASCUS and LSIL. A population-based follow-up study from Western Norway. Cancer Med. 2014 (in press).

  20. Ojesina AI, Lichtenstein L, Freeman SS, Pedamallu CS, Imaz-Rosshandler I, Pugh TJ, Cherniack AD, Ambrogio L, Cibulskis K, Bertelsen B, Romero-Cordoba S, Trevi帽o V, Vazquez-Santillan K, Guadarrama AS, Wright AA, Rosenberg MW, Duke F, Kaplan B, Wang R, Nickerson E, Walline HM, Lawrence MS, Stewart C, Carter SL, McKenna A, Rodriguez-Sanchez IP, Espinosa-Castilla M, Woie K, Bjorge L, Wik E, Halle MK, Hoivik EA, Krakstad C, Gabi帽o NB, G贸mez-Mac铆as GS, Valdez-Chapa LD, Garza-Rodr铆guez ML, Maytorena G, Vazquez J, Rodea C, Cravioto A, Cortes ML, Greulich H, Crum CP, Neuberg DS, Hidalgo-Miranda A, Escareno CR, Akslen LA, Carey TE, Vintermyr OK, Gabriel SB, Barrera-Salda帽a HA, Melendez-Zajgla J, Getz G, Salvesen HB, Meyerson M. Landscape of genomic alterations in cervical carcinomas. Nature. 2014 (in press).